BENEFITS | PITFALLS |
---|---|
✓ High-throughput technology progress | ✓ Great challenge for clinical use |
✓ Use and development of targeted drugs | ✓ New mutations with no drugs |
✓ Broad tumor characterization | ✓ Uncertainty in patient outcome |
✓ Identification of many diagnostic sub-populations | ✓ Many small sub-populations with poor statistical power |
✓ Simultaneous gene sequencing | ✓ Time consuming |
✓ Cost decrease | ✓ Not always accessible |
✓ Growing number of data | ✓ Difficult data interpretation and classification |
✓ Many newly discovered variants | ✓ Increase of VUS |